A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

摘要

Provided are formulations of a stable commercial paroxetine tablet comprising paroxetine hydrochloride anhydrous, povidone, copovidone or HPMC as a binder, and an HCI free/non-hygroscopic filler, prepared by the wet granulation method.